OXCARBAZEPINE
NDC 70518-2370, OXCARBAZEPINE, tablet, film coated, from REMEDYREPACK INC..
- Product NDC
- 70518-2370
- Status
- Listed
- Labeler
- REMEDYREPACK INC.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078069
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70518-2370 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXCARBAZEPINE300 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70518-2370-2 | 70518237002 | 100 POUCH in 1 BOX (70518-2370-2) / 1 TABLET, FILM COATED in 1 POUCH (70518-2370-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ffc8d10c-0049-4fe5-beb8-79cc6a197ede
Use it
Look up 70518-2370 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70518-2370 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70518-2370. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.